abrdn Healthcare Investors Shares of

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.

MURRAY INTERNATIONAL TRUST PLCMYI · Asset ManagementAberdeen, United Kingdom

68% matchPublic

Established in the United Kingdom on December 18, 1907, Murray International Trust PLC functions as a closed-ended equity investment fund. Its operations are overseen by Aberdeen Fund Managers Limited, with additional management responsibilities shared with Aberdeen Asset Managers Limited. The fund is dedicated to investing in global public equity markets, targeting a diverse array of companies across various sectors and all market capitalization sizes. Its investment strategy employs a top-down, fundamental analysis, incorporating factors such as company valuation, performance metrics, and broader macroeconomic and monetary trends to shape its portfolio. The Trust's performance is gauged against a composite benchmark comprising 40% of the FTSE World UK Index and 60% of the FTSE World ex UK Index.

Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund is a closed ended equity mutual fund launched and managed by Eaton Vance Management. It invests in public equity markets across the globe. The fund seeks to invest in the stocks of companies operating across diversified sectors. It primarily invests in dividend paying value stocks of companies. The fund employs fundamental analysis to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Index. Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund was formed on April 30, 2004 and is domiciled in the United States.

BIOTECH GROWTH TRUST (THE) PLCBIOG · Asset ManagementLondon, United Kingdom

66% matchPublic

The Biotech Growth Trust PLC, a closed-ended equity investment vehicle, was originally established by Frostrow Capital LLP and is jointly managed by OrbiMed Capital LLC. Formed on May 20, 1997, and legally based in the United Kingdom, this trust allocates its capital to global public equity markets. Its primary objective is to invest in shares of companies operating within the biotechnology sector, spanning the full range of market capitalizations. The construction of its investment portfolio relies on rigorous fundamental analysis, and its performance is benchmarked against the NASDAQ Biotechnology Index. It was previously identified as Finsbury Emerging Biotechnology Trust PLC.

The North American Income Trust plc, an exchange-traded fund overseen by Aberdeen Fund Managers Limited, allocates capital to public equity markets within the United States. Its strategy involves investing in the shares of large-capitalization companies, typically falling within the market capitalization range of the S&P 500 Index, across a diverse array of sectors. The portfolio benefits from an active management approach, with its performance benchmarked against the S&P 500 Index. Established in the United Kingdom on November 2, 1902, the trust was previously known as Edinburgh US Tracker Trust plc.